We are monitoring the impact of COVID-19 on MEA Metabolomics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Metabolomics Market Research Report - Segmented By Product, Indication, Application & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends, Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3323
Pages: 175

MEA Metabolomics Market Size (2022 to 2027)

The Middle East and Africa Metabolomics Market size have been estimated at USD 262.50 Million in 2022. It is further estimated to grow at a CAGR of 25% from 2027 and worth USD 801.09 Million by 2027.

Metabolomics is the significant scale research of little molecules, generally known as metabolites, inside cells, biofluids, tissues, or living beings. Metabolomics is a proficient approach since metabolites and their concentration, not like other "omics" measures, straightforwardly reflect the unseen biochemical movement and tissues' condition. Consequently, metabolomics signifies atomic phenotype. Aggregately, these little atoms and their associations inside an organic framework are known as the metabolome.

The emerging recognition of metabolomics in customized medicines is one of the key factors boosting the market's growth. The expanding biotech innovative work and pharmaceutical consumption prompt persistent headways in innovation, spelling development for the worldwide metabolomics market. The unexplored markets in rising countries will goad new development open doors for market players. Further, the requirement for precisely qualified specialists and the lack of the same is limiting the expansion of the metabolomics market. The Middle East and Africa's Metabolomics market are evolving at a rapid speed.

This research report on the Middle East and Africa Metabolomics Market has been segmented and sub-segmented into the following categories:

By Product: 

  • GC
  • Bioinformatics
  • Mass Spectrometry
  • HPLC
  • UPLC
  • NMRS
  • Surface-based mass analysis

By Indication: 

  • Oncology
  • Cardiology
  • Inborn Error

By Application: 

  • Nutrigenomics
  • Toxicology
  • Biomarker 
  • Drug Discovery

By Country: 

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA       

Based on Application, the Biomarker Discovery segment had the largest share in 2018 in the global metabolomics market. Efficiency and reliability have been cited as the reason for the growth of biomarkers. However, a collaboration between biotechnology and pharmaceutical companies, the personalized medical segment is expected to have the highest CAGR.

Based on the region, the Middle East and Africa have an untapped market, and key players are slowly expanding to this region, which is the main reason for the market's growth in this region.

Key Companies leading the Middle East & Africa Metabolomics Market profiled in this report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.).


                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Metabolomic Instruments                               


                                                       Gas Chromatography (GC)

                                                       Capillary Electrophoresis (CE)

                                                       High-performance Liquid Chromatography (HPLC)

                                                       Ultra-performance Liquid Chromatography (UPLC)

                                       Detection Tools 

                                                       Mass Spectrometry

                                                       Nuclear Magnetic Resonance Spectroscopy

                                                       Surface-Based Mass Analysis

                                5.1.2 Metabolomics Bioinformatics Tools and Services                   

                                       Bioinformatics Tools & Databases              

                                       Bioinformatics Services  

                                5.1.3 Y-o-Y Growth Analysis, By Product                               

                                5.1.4 Market Attractiveness Analysis, By Product                             

                                5.1.5 Market Share Analysis, By Product                               

                5.2 Indication                                    

                                5.2.1 Cancer                      

                                5.2.2 Cardiovascular Disorders                   

                                5.2.3 Inborn errors                         

                                5.2.4 Neurological Errors                              

                                5.2.5 Other Indications                 

                                5.2.4 Y-o-Y Growth Analysis, By Indication                           

                                5.2.5 Market Attractiveness Analysis, By Indication                         

                                5.2.6 Market Share Analysis, By Indication                           

                5.3 Application                                 

                                5.3.1 Nutrigenomics                       

                                5.3.2 Toxicology                               

                                5.3.3 Biomarker & Drug Discovery                            

                                5.3.4 Functional Genomics                          

                                5.3.5 Personalized Medicine                      

                                5.3.6 Other Applications

                                5.3.7 Y-o-Y Growth Analysis, By Application                         

                                5.3.8 Market Attractiveness Analysis, By Application                       

                                5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                                6.1.4 Market Attractiveness Analysis                      

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                                6.1.5 Market Share Analysis                       

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                6.2 Middle-East                                                

                6.3 Africa                                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Waters Corporation (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Human Metabolome Technologies, Inc. (Japan)                                        

                8.4 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.5 LECO Corporation (U.S.)                                        

                8.6 Bruker Corporation (U.S.)                                    

                8.7 Shimadzu Corporation (Japan)                                           

                8.8 Metabolon Inc. (U.S.)                                            

                8.9 Danaher Corporation (U.S.)                                 

                8.10 Biocrates Life Sciences AG (Austria)                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          


                a) List of Tables                                

                b) List of Figures                                              

  1. Middle East & Africa Metabolomics Market, By Product, From 2022 - 2027 (USD Million)
  2. The Middle East & Africa GC Market, By Region, From 2022 - 2027 (USD Million)
  3. The Middle East & Africa Bioinformatics Market, By Region, From 2022 - 2027 (USD Million)
  4. The Middle East & Africa Mass Spectroscopy Market, By Region, From 2022 - 2027 (USD Million)
  5. The Middle East & Africa HPLC Market, By Region, From 2022 - 2027 (USD Million)
  6. The Middle East & Africa UPLC Market, By Region, From 2022 - 2027 (USD Million)
  7. The Middle East & Africa NMRS Market, By Region, From 2022 - 2027 (USD Million)
  8. The Middle East & Africa Surface-Based Analysis Market, By Region, From 2022 - 2027 (USD Million)
  9. The Middle East & Africa Metabolomics Market, By Indication, From 2022 - 2027 (USD Million)
  10. The Middle East & Africa Oncology Market, By Region, From 2022 - 2027 (USD Million)
  11. The Middle East & Africa Cardiology Market, By Region, From 2022 - 2027 (USD Million)
  12. The Middle East & Africa Inborn Errors Market, By Region, From 2022 - 2027 (USD Million)
  13. The Middle East & Africa Metabolomics Market, By Application, From 2022 - 2027 (USD Million)
  14. The Middle East & Africa Nutrigenomics Market, By Region, From 2022 - 2027 (USD Million)
  15. The Middle East & Africa Toxicology Market, By Region, From 2022 - 2027 (USD Million)
  16. The Middle East & Africa Biomarker & Drug Discovery Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East Metabolomics Market, By Product, From 2022 - 2027 (USD Million)
  18. Middle East Metabolomics Market, By Indication, From 2022 - 2027 (USD Million)
  19. Middle East Metabolomics Market, By Application, From 2022 - 2027 (USD Million)
  20. Africa Metabolomics Market, By Product, From 2022 - 2027 (USD Million)
  21. Africa Metabolomics Market, By Indication, From 2022 - 2027 (USD Million)
  22. Africa Metabolomics Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample